Bioequivalence and Bioavailability Forum

Main page Policy Latest Posts Abbreviations

Biosimilars [Design Issues]

posted by M.Vasu – India, 2011-11-24 15:01 (5314 d 10:59 ago) – Posting: # 7712
Views: 10,664

Hi,

Can any one explain regarding BE study procedure for Biosimilars (Injection) in healthy subjets?

Thanks,

VM..........

Edit: Category changed. [Helmut]

Complete thread:

BiosimilarsM.Vasu 2011-11-24 14:01 [Design Issues]
- Biosimilars Helmut 2011-11-24 14:44
  - Biosimilars M.Vasu 2011-11-28 12:33
    - Healthy subjects vs. patients Helmut 2011-11-28 12:56
    - Biosimilars drgunasakaran1 2012-02-06 13:57
  - Biosimilars Ben 2011-12-16 19:04
- Biosimilars Chiku 2012-02-03 06:43
  - Biosimilars drgunasakaran1 2012-02-10 11:33
    - Biosimilars Chiku 2012-02-10 12:03
      - Biosimilars Kumarnaidu2 2021-10-22 07:53

Admin contact
23,653 posts in 4,991 threads, 1,571 registered users;
146 visitors (0 registered, 146 guests [including 52 identified bots]).
Forum time: 03:01 CEST (Europe/Vienna)

To propose that poor design can be corrected by subtle analysis techniques
is contrary to good scientific thinking. Stuart J. Pocock

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC

Ing. Helmut Schütz